Immunicum AB is a Swedish biotechnology company that developed allogeneic cell-based cancer immunotherapies, including the investigational product ilixadencel. Its programs were…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Immunicum →Already a subscriber? Sign in
Xcout Intel tracks Immunicum continuously — this profile deepens as new filings, funding, people and hiring data arrive.